Meeting
2024 ASCO Breakthrough
Circulating tumor DNA for predicting radiographic and pathologic response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-1.
Authors
Yoshinori Kagawa
Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan
Yoshinori Kagawa , Jun Watanabe , Mamoru Uemura , Koji Ando , Akira Inoue , Yujiro Nishizawa , Yusuke Suwa , Keigo Chida , Tsuyoshi Hata , Yuki Sekido , Ryota Nakanishi , Koichi Okuya , Masaaki Miyo , Koji Oba , George Laliotis , Yoshiaki Nakamura , Hideaki Bando , Takayuki Yoshino , Ichiro Takemasa , Eiji Oki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies
Sub Track
Multimodality Treatments
Clinical Trial Registration Number
jRCTs051200113
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 71)
DOI
10.1200/JCO.2024.42.23_suppl.71
Abstract #
71
Poster Bd #
E3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The prediction of pathological complete response after total neoadjuvant therapy for locally advanced rectal cancer using versatile liquid biopsy.
First Author: Akihisa Matsuda
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
No operation after short course radiotherapy followed by consolidation chemotherapy in locally advanced rectal cancer: The prospective, single arm NOAHS-ARC trial.
First Author: Felipe Fernando Quezada
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A prospective multicenter phase II trial of total neoadjuvant therapy for locally advanced rectal cancer in JAPAN: ENSEMBLE-1 study.
First Author: Yoshinori Kagawa